ctDNA informs management of metastatic breast cancer

Circulating tumour DNA (ctDNA) testing should be incorporated into the management of patients with metastatic breast cancer (mBC), according to Australian researchers. A prospective ctDNA testing program at the Peter MacCallum Cancer Centre, Melbourne, has shown the approach is feasible and valuable as a complement to standard tumour testing in newly diagnosed and established metastatic ...

Already a member?

Login to keep reading.

© 2020 the limbic